Gastrointestinal Disorders
Monteresearch S.r.l. is focused on clinical research in bile acid diarrhoea, with interest in conditions that affect intestinal fluid handling, stool consistency, and chronic diarrhoeal symptoms.
- Chronic diarrhoea
- Intestinal malabsorption
- Digestive symptom control
Its research activity is centred on therapeutic options for patients with moderate-to-severe disease in the gastroenterology field.
Bile Acid–Related Therapy
The sponsor’s clinical interest includes treatments targeting bile acid imbalance and its role in persistent diarrhoeal symptoms, with attention to therapies that improve remission in this disorder.
- Bile acid sequestration
- Colesevelam
- Symptom remission
This area reflects a therapeutic focus on managing disorders linked to abnormal bile acid exposure in the intestinal tract.
Diagnostic-Guided Treatment
Clinical work is aligned with patients identified through 75SeHCAT diagnostic criteria, indicating interest in treatment strategies for confirmed bile acid diarrhoea populations.
- Moderate-to-severe disease
- Diagnostic confirmation
- Patient stratification
The sponsor’s research activity connects diagnostic classification with targeted care in functional bowel disorders.
Placebo-Controlled Clinical Evaluation
Monteresearch S.r.l. supports clinical assessment of a delayed-release formulation designed for gastrointestinal delivery, with emphasis on treatment response and safety in adults with persistent diarrhoea.
- Delayed-release formulation
- Treatment efficacy
- Safety evaluation
Its research landscape is concentrated in medical therapy development for a single digestive indication.
